The amount of international aid given to address noncommunicable diseases is minimal. Most of it is directed to wealthier countries and focuses on the prevention of unhealthy lifestyles. Explanations for the current direction of noncommunicable disease aid include that these are diseases of affluence that benefit from substantial research and development into their treatment in high-income countries and are better addressed through domestic tax and policy measures to reduce risk-factor prevalence than through aid programs. This study assessed these justifications. First, we examined the relationships among premature adult mortality, defined as the probability that a person who has lived to the age of fifteen will die before the age of sixty from noncommunicable diseases; the major risk factors for these diseases; and country wealth. Second, we compared noncommunicable and communicable diseases prevalent in poor and wealthy countries alike, and their respective links to economic development. Last, we examined the respective roles that wealth and risk prevention have played in countries that achieved substantial reductions in premature mortality from noncommunicable diseases. Our results support greater investment in cost-effective noncommunicable disease preventive care and treatment in poorer countries and a higher priority for reducing key risk factors, particularly tobacco use.
Once thought to be challenges for affluent countries alone, cancer, cardiovascular diseases, diabetes, and other noncommunicable diseases are now the leading cause of death and disability in developing countries. The economic and human costs are high and rising in low- and middle-income countries, threatening their continued development prosperity. Lung, liver, cervical and breast cancers constitute a large proportion of this growing burden and can be addressed with life-saving and low-cost interventions.
This article, published in Duke University’s Journal of Health Politics, Policy and Law, examines the role of international institutional actors in China’s health policy process. Particular attention is paid to three major international institutional actors: the World Bank, the World Health Organization, and the Global Fund to Fight AID, Tuberculosis and Malaria.
This study explores the role of domestic politics in China’s health-related development assistance to Africa. It identifies domestic politics as a constant, even critical, component in shaping and structuring China’s health aid to Africa.
Once thought to challenge only affluent countries, cardiovascular disease, cancer, diabetes, and other non-communicable diseases (NCDs) are now the leading cause of death and disability in low-income and middle-income countries. International efforts should focus on specific NCDs and risk factors that are prevalent in poor working-age (younger than 60 years) people in low-income and middle-income countries, and for which there are low-cost interventions that can be integrated with existing global health platforms.
A SARS-like disease called Middle East Respiratory Syndrome (MERS) that kills a third of those it infects is suddenly, and mysteriously, surging inside Saudi Arabia. Laurie Garrett examines some of the possible causes and analyzes what steps need to be taken to prevent a global outbreak.
New shots are jeopardizing humanity's battle to eradicate polio, and they don't include syringes or vaccines. Rather, they're the gunshots of Islamic terrorists, and they're imperiling the fight to eliminate polio.
Authors: Yanzhong Huang, Kalipso Chalkidou, Robert Marten, Derek Cutler, Tony Culyer, Richard Smith, Yot Teerawattananon, Francoise Cluzeau, Ryan Li, Richard Sullivan, Victoria Fan, Amanda Glassman, Yu Dezhi, Sam McPherson, Thiagarajan Sundararaman, Neil Squires, Nils Daulaire, Rajeev Sadanandan, and Alexandre Lemgruber The Lancet
Yanzhong Huang and colleagues examine universal health coverage and the role of technology.
Authors: Yanzhong Huang, Patricia Moser, and Susann Roth Asian Development Bank
Yanzhong Huang, Patricia Moser, and Susann Roth discuss the key health challenges in the post-2015 development agenda for Asia and the Pacific, a highly populated, diverse region of countries with different health needs and priorities.
Thomas Bollyky describes the crisis emerging over access to treatment for diabetes, cancers, and other non-communicable diseases (NCDs). Bollyky argues that this crisis could transform the global response to NCDs as the last treatment access crisis transformed the international approach to HIV/AIDS.
Without a more transparent international research and information-sharing system, Middle East respiratory syndrome (MERS) could spread far beyond the bounds of the region for which it is named, write Laurie Garrett and Maxine Builder.
Read Yanzhong Huang's chapter titled "Global Health,Civil Society, and Regional Security," in the book A Growing Force for Good: Civil Society's Role in Asian Regional Security, edited by Rizal Sukma and James Gannon.
Learn more about CFR’s mission and its work over the past year in the 2016 Annual Report. The Annual Report spotlights new initiatives, high-profile events, and authoritative scholarship from CFR experts, and includes a message from CFR President Richard N. Haass. Read and download »